MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
112.26%
Quick Ratio
99.82%
Cash Ratio
44.55%
Unit: Thousand (K) dollars
Assets Breakdown
Intangible assets, net
Cash and cash equivalents
Accounts receivable, net
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
26,715
30,025
32,630
30,952
Accounts receivable, net
24,489
30,923
33,225
31,155
Inventories
7,460
8,656
10,100
11,434
Prepaid expenses and other current assets
8,662
6,637
5,154
5,638
Current assets of discontinued operations
-
-
-
0
Total current assets
67,326
76,241
81,109
79,179
Property and equipment, gross
1,209
1,252
1,235
1,246
Less accumulated depreciation and amortization
802
768
735
714
Property and equipment, net
407
484
500
532
Operating lease right-of-use assets
910
959
1,010
1,061
Intangible assets, net
42,490
43,578
41,430
42,201
Other non-current assets
556
738
939
1,204
Non-current assets of discontinued operations
-
-
-
0
Total non-current assets
44,363
45,759
43,879
44,998
Total assets
111,689
122,000
124,988
124,177
Accounts payable
13,214
14,259
12,342
10,601
Accrued liabilities
34,270
40,156
36,700
38,164
Revolving credit facility
10,411
9,075
14,873
9,063
Current portion of debt
1,857
1,857
1,857
1,857
Other current liabilities
220
216
221
3,379
Current liabilities of discontinued operations
-
-
-
0
Total current liabilities
59,972
65,563
65,993
63,064
Debt, net of current portion
9,549
9,998
10,447
10,895
Derivative warrant liabilities
2,182
27,337
20,424
26,334
Other non-current liabilities
4,843
4,901
4,953
4,918
Total non-current liabilities
16,574
42,236
35,824
42,147
Preferred stock, par value .0001 50,000,000 shares authorized no shares issued or outstanding
-
-
-
0
Common stock, par value 0.0001 200,000,000 shares authorized 10,733,208 and 8,976,913 shares issued and outstanding, respectively
1
1
1
1
Additional paid-in capital
382,914
356,354
354,740
352,500
Accumulated deficit
-347,772
-342,154
-331,570
-333,535
Total stockholders equity
35,143
14,201
23,171
18,966
Total liabilities and stockholders equity
111,689
122,000
124,988
124,177
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Property and equipment,
gross
$1,209K
Cash and cash
equivalents
$26,715K
Accounts receivable, net
$24,489K
Prepaid expenses and
other current assets
$8,662K
Inventories
$7,460K
Intangible assets, net
$42,490K
Operating lease
right-of-use assets
$910K
Other non-current
assets
$556K
Property and equipment,
net
$407K
Less accumulated
depreciation and...
$802K
Total current assets
$67,326K
Total non-current
assets
$44,363K
Total assets
$111,689K
Total liabilities and
stockholders equity
$111,689K
Total current
liabilities
$59,972K
Total stockholders
equity
$35,143K
Total non-current
liabilities
$16,574K
Accumulated deficit
-$347,772K
Accrued liabilities
$34,270K
Accounts payable
$13,214K
Revolving credit facility
$10,411K
Current portion of debt
$1,857K
Other current
liabilities
$220K
Additional paid-in capital
$382,914K
Debt, net of current
portion
$9,549K
Other non-current
liabilities
$4,843K
Derivative warrant
liabilities
$2,182K
Common stock, par value
0.0001 200,000,000...
$1K
Buy us a coffee
AYTU BIOPHARMA, INC (AYTU)
AYTU BIOPHARMA, INC (AYTU)